Healthcare -
Biotechnology - NASDAQ - US
$ 30.75
-0.646 %
$ 13.7 B
Market Cap
12.11
P/E
RPRX - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative RPRX - Royalty Pharma plc
250 M
LAST VALUE
16.88%
2 YEAR CAGR
32.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR